{
    "id": "correct_subsidiary_00047_1",
    "rank": 25,
    "data": {
        "url": "https://www.life-sciences-usa.com/organisation/connetics-corporation-gsk-group-stiefel-laboratories-inc-palo-2001-6686.html",
        "read_more_link": "",
        "language": "en",
        "title": "The Transatlantic Life Sciences Web Portal",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.life-sciences-usa.com/images/basics/lsus-life-sciences-usa-portal-logo.svg",
            "https://www.life-sciences-usa.com/banner/ebd-group-20230818-650-100-world-of-partnering-opportunities.jpg",
            "https://www.life-sciences-usa.com/images/function/weblink_extern.gif",
            "https://www.life-sciences-usa.com/images/content/period_n.gif",
            "https://www.life-sciences-usa.com/images/content/product_n.gif",
            "https://www.life-sciences-usa.com/images/content/region_n.gif",
            "https://www.life-sciences-usa.com/banner/ebd-group-20240621-650-200-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-usa.com/banner/ebd-group-20240621-650-300-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-usa.com/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg",
            "https://www.life-sciences-usa.com/banner/demy-colton-20240611-120-240-biofuture-2024-conference-nyc-2-game-changers.png",
            "https://www.life-sciences-usa.com/banner/ebd-group-20230818-120-240-world-of-partnering-opportunities.jpg",
            "https://www.life-sciences-usa.com/banner/consultech-20230614-120-180-secure-funding-rnd-grants-for-pharma-biotech_1.png",
            "https://www.life-sciences-usa.com/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg",
            "https://www.life-sciences-usa.com/banner/kentro-design-20240415-120-180-design-is-key-to-your-success.jpg",
            "https://www.life-sciences-usa.com/banner/consultech-20230614-120-180-secure-funding-rnd-grants-for-pharma-biotech_2.png",
            "https://www.life-sciences-usa.com/banner/ebd-group-20240621-120-240-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-usa.com/banner/bionter-20230515-120-180-supplier-for-particle-testing.png",
            "https://www.life-sciences-usa.com/banner/demy-colton-20240611-120-240-biofuture-2024-conference-nyc-3-event.png",
            "https://www.life-sciences-usa.com/banner/ebd-group-20240621-120-240-bio-europe-2024-beu24-stockholm.jpg",
            "https://www.life-sciences-usa.com/banner/ebd-group-20230818-120-240-world-of-partnering-opportunities.jpg",
            "https://www.life-sciences-usa.com/banner/kentro-design-20190507-120-120-corporate-and-web-design-berlin.jpg",
            "https://www.life-sciences-usa.com/banner/demy-colton-20240611-120-240-biofuture-2024-conference-nyc-3-event.png",
            "https://www.life-sciences-usa.com/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg",
            "https://www.life-sciences-usa.com/images/basics/linkedin.svg",
            "https://www.life-sciences-usa.com/images/basics/twitter.svg",
            "https://www.life-sciences-usa.com/images/basics/lse-life-sciences-europe-portal-logo.svg",
            "https://www.life-sciences-usa.com/images/basics/msc-mass-spec-capital-portal-logo.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "life sciences",
            "biotechnology",
            "North America",
            "USA",
            "Canada",
            "Europe",
            "Israel",
            "UK",
            "Great Britain",
            "GB",
            "Germany",
            "France",
            "Benelux",
            "Scandinava",
            "Nordic Countries",
            "EMEA",
            "business intelligence",
            "economics",
            "mass spectrometry",
            "biochips",
            "microarrays",
            "proteomics",
            "genomics",
            "metabolomics",
            "molecular diagnostics",
            "bioinformatics",
            "laboratory equipment",
            "drug discovery",
            "laboratory \n                             automation",
            "business development",
            "market research",
            "property rights",
            "industrial organisation",
            "news",
            "deals",
            "products",
            "persons",
            "financings",
            "collaborations",
            "cancer",
            "infection"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Life Sciences Business Intelligence Web Portal for North America, Europe and Israel",
        "meta_lang": "",
        "meta_favicon": "https://www.life-sciences-usa.com/favicon.ico",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Advertisement\n\nOrganisation › Details\n\nConnetics Corporation\n\nhttps://www.connetics.com\n\nStart 1999-08-10 existent Group GSK (Group) Today Stiefel Laboratories Inc. Successor Stiefel Laboratories Inc. Industry dermatic Region Palo Alto, CA Country United States (USA) Street 3160 Porter Drive City 94304 Palo Alto, CA Address record changed: 2020-12-02 Basic data Employees n. a.\n\nRecord changed: 2023-07-10\n\nAdvertisement\n\nMore documents for GSK (Group)\n\n[1] CureVac N.V.. (7/3/24). \"Press Release: GSK and CureVac to Restructure Collaboration into New Licensing Agreement\". London, Tübingen & Boston, MA....\n\n[2] GSK plc. (6/6/24). \"Press Release: GSK Accelerates Oligonucleotide Platform and Pipeline Medicines with Acquisition of Elsie Biotechnologies [For media and investors only]\". London....\n\n[3] Forbion Capital Partners. (1/9/24). \"Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion\"....\n\n[4] GSK plc. (1/9/24). \"Press Release: GSK Enters Agreement to Acquire Aiolos Bio\"....\n\n[5] CureVac N.V.. (1/5/24). \"Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform\". Tübingen & Boston, MA....\n\n[6] GSK plc. (12/20/23). \"Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093\". London....\n\n[7] Aiolos Bio, Inc.. (10/24/23). \"Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody\". San Francisco, CA & London....\n\n[8] GSK plc. (6/28/23). \"Press Release: GSK Completes Acquisition of Bellus Health [For media and investors only]\". London....\n\n[9] GSK plc. (4/18/23). \"Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Bellus Health [For media and investors only]\". London....\n\n[10] CureVac N.V.. (1/6/23). \"Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs\". Tübingen & Boston, MA....\n\nTo subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«\n\nFind more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]\n\nAdvertisement\n\n» top"
    }
}